Published in Vaccine Weekly, August 21st, 2002
Robert M. Prins and his associates at Virginia Commonwealth University inoculated rats with T9 glioma cells (5x104) intracranially (i.c.) and allowed the tumors to grow for 5 days. On the fifth day, the animals received subcutaneous vaccination with irradiated T9.F glioma cells (5x106). The investigators found that vaccination actually shortened survival time compared with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.